Acadian Asset Management’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,868
Closed -$19K 1686
2023
Q4
$19K Sell
8,868
-8,742
-50% -$18.7K ﹤0.01% 1593
2023
Q3
$50K Buy
+17,610
New +$50K ﹤0.01% 1431
2021
Q1
Sell
-566,314
Closed -$3.4M 2191
2020
Q4
$3.4M Buy
566,314
+179,630
+46% +$1.08M 0.01% 608
2020
Q3
$2.87M Sell
386,684
-945,502
-71% -$7.02M 0.01% 572
2020
Q2
$5.35M Sell
1,332,186
-208,550
-14% -$837K 0.02% 470
2020
Q1
$3.91M Sell
1,540,736
-146,945
-9% -$373K 0.02% 443
2019
Q4
$5.87M Buy
1,687,681
+417,327
+33% +$1.45M 0.03% 407
2019
Q3
$5.88M Buy
1,270,354
+215,610
+20% +$998K 0.03% 439
2019
Q2
$13M Buy
1,054,744
+208,982
+25% +$2.57M 0.06% 243
2019
Q1
$11.2M Buy
845,762
+307,013
+57% +$4.08M 0.05% 278
2018
Q4
$4.64M Buy
538,749
+62,686
+13% +$540K 0.02% 387
2018
Q3
$3.57M Buy
476,063
+49,972
+12% +$374K 0.01% 439
2018
Q2
$2.54M Buy
426,091
+124,708
+41% +$743K 0.01% 504
2018
Q1
$1.76M Buy
301,383
+154,678
+105% +$904K 0.01% 613
2017
Q4
$864K Buy
146,705
+59,839
+69% +$352K ﹤0.01% 715
2017
Q3
$438K Sell
86,866
-94,521
-52% -$477K ﹤0.01% 805
2017
Q2
$732K Sell
181,387
-120,318
-40% -$486K ﹤0.01% 756
2017
Q1
$1.72M Buy
301,705
+95,056
+46% +$541K 0.01% 658
2016
Q4
$1.5M Sell
206,649
-37,809
-15% -$275K 0.01% 643
2016
Q3
$1.96M Sell
244,458
-21,532
-8% -$173K 0.01% 551
2016
Q2
$2.4M Sell
265,990
-161,066
-38% -$1.45M 0.01% 491
2016
Q1
$3.45M Buy
427,056
+337,583
+377% +$2.72M 0.02% 458
2015
Q4
$968K Buy
+89,473
New +$968K 0.01% 696